Phoenix-Micron, Inc. is a pioneering company in the field of in vivo ophthalmic imaging for small animal research. Founded in 2007, the company has established itself as a global leader, with its MICRON systems being deployed in over 25 countries and utilized by renowned research institutes. The company's patented MICRON platform offers seven essential imaging modalities, tailored for eye and eye-brain research, making it an ideal solution for small animal research labs with stringent data capture and space requirements.
The Health Care industry, where Phoenix-Micron operates, presents significant growth opportunities. The company's focus on precision ophthalmic imaging aligns with the increasing demand for advanced research tools in this sector, indicating strong market potential.
Phoenix-Micron's commitment to delivering world-class service, coupled with its track record of adoption by leading research institutes and authors of over 450 published studies, underscores its credibility and impact within the scientific community. Although specific details on the last investment and investors are not available, the company's consistent growth and prominent presence in top research facilities position it as an attractive prospect for potential investors seeking exposure in the burgeoning field of ophthalmic research.
There is no investment information
No recent news or press coverage available for Phoenix-Micron, Inc. .